MedTrace Logo

Safety and Efficacy of Virtual Reality Mindfulness in Patients With Psychosis

NCT05784948 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 67

Last updated 2023-04-10

No results posted yet for this study

Summary

This study is to evaluate the safety and efficacy of Virtual Reality Mindfulness in Patients With Psychosis.

Conditions

  • Schizophrenia Spectrum Disorders
  • Schizophrenia
  • Schizoaffective Disorder
  • Schizophreniform Disorders
  • Psychotic Disorder Not Otherwise Specified

Interventions

OTHER

Virtual Reality Mindfulness Treatment

once a week for 30 minutes, over 8 weeks

OTHER

Experience relaxing scenery and music

once a week for 30 minutes, over 8 weeks

Sponsors & Collaborators

  • Chonbuk National University Hospital

    lead OTHER

Principal Investigators

  • Young-chul Chung, MD · Chonbuk National University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
15 Years
Max Age
59 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-04-08
Primary Completion
2021-06-09
Completion
2021-06-09

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05784948 on ClinicalTrials.gov